Skip to content
science — medical-conditions — chronic-diseases — cance — respiratory-conditions — digestive-health — Eye-health — hearing — autoimmune-disorders — Climate-change — cardiovascular-health — Industry — neurological-disorders — environmental-science — Finance — skin-conditions — space-and-astronomy — Cybersecurity — Lifestyle — Fashion-and-beauty — Food-and-drink — Investing — Home-and-garden — Business — Personal-finance — Gadgets — data-and-cloud-computing — Technology — artificial-intelligence — Relationships — Pets — travel — Cars — Books — **Headline:** Spin into Fun: Explore Our Top Games! — Personal-growth — shopping — Social-media — movies-and-tv — Career-development — All about casino & gambling. — Entertainment — Celebrities — music — Politics — Pop-culture — Sci-fi-and-fantasy — General-news — Crime-and-justice — learning — Sports — Football — soccer — Baseball — Basketball — American-football

Autoimmune Disorder Antiphospholipid Syndrome (APS) Linked to Increased Blood Clotting Condition Known as Thrombophilia

Blood condition known as Antiphospholipid Syndrome (APS) is categorized as an autoimmune disorder that leads to the formation of unusual blood clots. autoimmune disorders manifest when the immune system malfunctions, attacking the body's own cells and tissues.

,   and  Administrator
2 min read
Autoimmune Condition Leading to Thrombophilia: Insight into Antiphospholipid Syndrome (APS)
Autoimmune Condition Leading to Thrombophilia: Insight into Antiphospholipid Syndrome (APS)

A Deep Dive into Antiphospholipid Syndrome (APS)

Autoimmune Disorder Antiphospholipid Syndrome (APS) Linked to Increased Blood Clotting Condition Known as Thrombophilia

Antiphospholipid Syndrome (APS) is an autoimmune blood disorder that leads to the formation of abnormal blood clots, causing serious health issues. This condition is diagnosed based on the presence of antiphospholipid antibodies, which can be found in three types: Lupus anticoagulants (LA), Anti-beta-2-glycoprotein-I (anti-β2GPI) antibodies, and Anticardiolipin antibodies (aCL).

Primary APS

Primary APS occurs independently without any other underlying autoimmune condition. The exact cause of primary APS is not fully understood, but it is thought to be related to genetic and environmental factors that trigger the production of antiphospholipid antibodies, which are a hallmark of the syndrome. These antibodies can cause blood clots and other symptoms associated with APS.

Secondary APS

Secondary APS is associated with other autoimmune diseases, most commonly systemic lupus erythematosus (SLE). Other factors that can contribute to secondary APS include rheumatoid arthritis, scleroderma, infections, and certain medications. Patients with SLE have a higher risk of developing APS.

In secondary APS, there is evidence of clinical conditions such as autoimmune diseases, drugs, infections, or cancer. In 40% of the cases, APS is primary with no evidence of associated autoimmune conditions.

Certain medications, such as Chlorpromazine, Hydralazine, Amoxicillin, Quinidine, Interferon alpha, Phenytoin, Cysteamine, Oral contraceptives, Propranolol, and Tumor necrosis factor alpha inhibitors, have been associated with APS.

Catastrophic Antiphospholipid Syndrome (CAPS)

Catastrophic antiphospholipid syndrome (CAPS) is a rare but severe complication of APS, affecting fewer than 1% of patients and carrying a high mortality rate. CAPS causes widespread blood clots in multiple organs within days, leading to complications in the lungs, kidneys, heart, brain, skin, and digestive system. Common triggers for CAPS include stopping anticoagulation, infections, and surgery.

Diagnosis of APS and CAPS

APS is diagnosed based on the presence of antiphospholipid antibodies and clinical manifestations such as recurrent thrombosis or pregnancy complications. In the case of Obstetrics APS, pregnancy complications like severe preeclampsia, fetal loss, placental insufficiency, or recurrent miscarriages, along with specific laboratory criteria for APLA, are considered.

CAPS is mainly diagnosed based on four criteria: Involvement of at least three organs, symptoms appearing within a week, lab confirmation of APLA, and biopsy evidence of small blood vessel blockages. Thrombotic antiphospholipid syndrome is diagnosed based on thrombosis in the arteries or veins and continuous laboratory requirement for the diagnosis of antiphospholipid antibodies.

In conclusion, APS is a significant health concern due to its potential to cause serious complications. Understanding the different types of APS, its triggers, and the methods for diagnosis can aid in early detection and effective management of this condition.

Read also:

Related

Latest